As of 4th November 2022, Stemcell First Sdn Bhd has reduced its minimum fundraising amount to RM200,000. With the reduction of the minimum fundraising goal, the promoter has stated that there will be no revision to the business plan and forecast as alternative funding will be explored to meet the minimum financial requirement for the acquisition of CAR-T distribution rights. The promoter has undertaken to provide financial and operational support for the company of at least twelve (12) months should the company fail to achieve its maximum fundraising target amount to ensure that its financial forecasts are met. Further details of the revision on the utilisation of proceeds have been highlighted in red font and can be found in The Offering section.
This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007. This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund-raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
iPivot makes no financial recommendation for the offer. You are advised to read and understand the contents of the document and to consult your professional adviser prior to making an investment decision.